Minoryx

Developer of therapies for rare neurometabolic diseases

placeMataro, Catalonia, Spain calendar_todayFounded 2011 groups33 employees language minoryx.com

Registered entities

Social engagement

Social engagement: 8.8K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

22 investors on record; lead investors include Columbus Venture Partners, Caixa Capital Risc, Fund+, Ysios Capital.

Investor typeCountShare
Venture capital941%
Private equity627%
Accelerator & incubator15%
Other / undisclosed627%

Recent activity

23 Jul 2025
Partnership
Europe Neuraxpharm
Coming soon